This morning, USA-based biotech AirNexis Therapeutics announced its launch with the close of its oversubscribed $200 million ...
32 Biosciences revealed its plan to launch a $40 million Series A at this year’s J.P Morgan Healthcare conference, to advance ...
AN AMBULANCE stopped to refuel on the way to a dying man who was struggling to breathe despite having almost half a tank of ...
AirNexis has handed over $40 million cash for Haisco’s HSK39004, coded by AirNexis as AN01. Under the terms of the deal, ...
AirNexis Therapeutics, a clinical stage biotech company developing therapeutics for pulmonary diseases, today announced the close of a $200 million Series A financing round and the in-license of a ...
Fife Today on MSN
Fife gran’s pledge to walk 60km in six days in fundraiser in memory of family members
A grandmother from Fife is undergoing an ambitious personal challenge to walk 60km in six days raising funds for the British ...
Onlymyhealth on MSN
Breathless while talking or climbing few steps? Know early COPD signs people shouldn't ignore here
If you often feel short of breath when you talk, walk a short distance, or use the stairs, you might think it is just a ...
Asthma and COPD Drugs Market is expected to reach US$ 82.2 Billion by 2036, driven by Advancements in Drug Discovery and ...
The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneously administered therapy for patients with epidermal growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback